Home

Pureos Bioventures

Pureos Bioventures

Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. The fund’s portfolio companies are built on scientific excellence to develop therapies across a broad indication spectrum including oncology, immunology, ophthalmology, rare diseases, and neuroscience. Pureos has built a team with deep investment, operating and clinical expertise, that strives to impact patients’ lives by advancing innovative treatments for devastating diseases.
Investor Type:
VC Firm
HQ Location:
Switzerland
Investment Areas:
Diagnostics, Biopharma, Biotech, Life Sciences
Typical Investment:
Above €3M
Funding Stage:
Series A/B, Series C & Beyond
Contact Email:
[email protected]